Gene Editing Market Size, Share, Trends, Growth Outlook

Gene Editing Market is estimated to increase at a Compounded Annual Growth Rate of 16.5% CAGR over the forecast period from 2024 to 2030

The Gene Editing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Reagents & Consumables, Software & Systems, Services), By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Others), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others).

An Introduction to Gene Editing Market in 2024

Gene editing, also known as genome editing, is a molecular biology technique used to modify the DNA sequence of an organism's genome with precision and specificity. In 2024, gene editing technologies have revolutionized biomedical research, biotechnology, and medicine by enabling targeted modifications, deletions, insertions, or corrections of genetic sequences in cells and organisms. Gene editing techniques, such as CRISPR-Cas9, TALENs, and zinc finger nucleases (ZFNs), allow researchers to edit genes with unprecedented accuracy and efficiency by introducing double-strand breaks (DSBs) at specific genomic loci and harnessing the cell's natural DNA repair mechanisms to achieve desired genetic changes. Gene editing holds immense promise for applications in basic research, including functional genomics, gene knockout studies, and disease modeling, as well as translational research and therapeutic development, such as gene therapy, cell therapy, and precision medicine. In biomedical applications, gene editing technologies offer potential treatments for genetic disorders, cancer, infectious diseases, and autoimmune diseases by correcting disease-causing mutations, enhancing immune responses, or modifying cellular pathways. Moreover, gene editing has implications for agriculture, bioproduction, and environmental conservation by engineering crops for improved yield, quality, and resilience, as well as modifying microbes for bioremediation or biomanufacturing purposes. With ongoing advancements in gene editing tools, delivery methods, and safety protocols, researchers continue to expand the capabilities and applications of gene editing technology, paving the way for innovative solutions to pressing scientific and societal challenges.

Market Trend: Advancements in CRISPR-Cas Technology

A prominent trend in the gene editing market is the rapid advancements in CRISPR-Cas technology. CRISPR-Cas systems have revolutionized the field of gene editing by offering precise and efficient tools for modifying DNA sequences in various organisms. With continuous improvements in CRISPR-Cas components, such as Cas nucleases, guide RNAs, and delivery methods, there's a growing ability to target specific genes with unprecedented accuracy and specificity. Additionally, innovations such as base editing and prime editing further expand the capabilities of CRISPR technology, allowing for precise nucleotide changes and gene corrections. This trend towards advancements in CRISPR-Cas technology fuels innovation and drives growth in the gene editing market, unlocking new possibilities for therapeutic applications, agricultural biotechnology, and basic research.

Market Driver: Increasing Demand for Therapeutic Genome Editing

A primary driver fueling the growth of the gene editing market is the increasing demand for therapeutic genome editing solutions. Gene editing technologies hold immense promise for treating genetic disorders, cancer, infectious diseases, and other medical conditions by correcting disease-causing mutations and modulating gene expression. With the advent of CRISPR-based therapeutics and ongoing clinical trials exploring gene editing as a treatment modality, there's growing interest from pharmaceutical companies, biotech startups, and academic research institutions in developing gene editing therapies. The potential to cure previously untreatable genetic diseases and provide personalized treatments tailored to individual patients drives investment and innovation in therapeutic genome editing, propelling market expansion and adoption of gene editing technologies in the healthcare sector.

Market Opportunity: Expansion into Agriculture and Food Security

An enticing opportunity within the gene editing market lies in expanding applications into agriculture and food security. Gene editing technologies offer powerful tools for improving crop traits such as yield, disease resistance, and nutritional content, contributing to global efforts to enhance agricultural productivity and address food security challenges. By precisely modifying plant genomes, gene editing enables the development of crops with desirable traits that are more resilient to environmental stressors, pests, and pathogens. Furthermore, gene-edited crops can offer nutritional enhancements and reduced reliance on chemical inputs, promoting sustainable agriculture practices and addressing consumer demands for healthier and more sustainable food options. By leveraging gene editing technologies in agriculture, companies can tap into new markets, drive innovation in crop improvement, and contribute to global food security initiatives, presenting opportunities for market diversification and growth beyond traditional therapeutic applications. This strategic expansion into agriculture aligns with the broader impact of gene editing on society and presents opportunities for market differentiation and value creation in the competitive gene editing market.

Gene Editing Market Share Analysis: CRISPR Technology is the fastest growing segment over the forecast period to 2030

In the Gene Editing Market, the segment experiencing the most rapid growth is CRISPR technology. This growth is propelled by several key factors. Firstly, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology offers unparalleled precision, efficiency, and versatility in gene editing, making it a highly sought-after tool in both research and therapeutic applications. Its ease of use and ability to target specific genomic sequences with unprecedented accuracy have revolutionized the field of genetic engineering, enabling scientists to edit genes with unprecedented precision and efficiency. Additionally, the continuous advancements in CRISPR-based tools and techniques, such as base editing and prime editing, further enhance its applicability and utility across a wide range of applications, including cell line engineering, genetic engineering, and drug discovery. Moreover, the growing investment in CRISPR-based therapeutics by pharmaceutical and biotechnology companies, coupled with the increasing adoption of CRISPR technology in academic and research institutes worldwide, drives the rapid expansion of the CRISPR technology segment within the Gene Editing Market. As a result, CRISPR technology emerges as the fastest growing segment, poised to shape the future of gene editing and genetic manipulation.

Gene Editing Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAgilent Technologies Inc, AMS Biotechnology Ltd, Beam Therapeutics Inc, Bluebird Bio Inc, Caribou Biosciences Inc, Cellectis S.A., Creative Biogene, CRISPR Therapeutics AG, Editas Medicine Inc, GenScript Biotech Corp, Inscripta Inc, Intellia Therapeutics Inc, Lonza Group Ltd, Mammoth Biosciences Inc, Merck KGaA, New England Biolabs Inc, OriGene Technologies Inc, PerkinElmer Inc, Precision Biosciences Inc, Regeneron Pharmaceuticals Inc, Sangamo Therapeutics Inc, Synthego Corp, Tecan Group Ltd, Thermo Fisher Scientific Inc

Gene Editing Market Segmentation

By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Gene Editing Market Companies

Agilent Technologies Inc
AMS Biotechnology Ltd
Beam Therapeutics Inc
Bluebird Bio Inc
Caribou Biosciences Inc
Cellectis S.A.
Creative Biogene
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript Biotech Corp
Inscripta Inc
Intellia Therapeutics Inc
Lonza Group Ltd
Mammoth Biosciences Inc
Merck KGaA
New England Biolabs Inc
OriGene Technologies Inc
PerkinElmer Inc
Precision Biosciences Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Synthego Corp
Tecan Group Ltd
Thermo Fisher Scientific Inc

Reasons to Buy the Gene Editing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Gene Editing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Gene Editing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Gene Editing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Gene Editing Market Size Outlook, $ Million, 2021 to 2030
3.2 Gene Editing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Gene Editing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Gene Editing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Gene Editing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Gene Editing Industry
4.2 Key Market Trends in Gene Editing Industry
4.3 Potential Opportunities in Gene Editing Industry
4.4 Key Challenges in Gene Editing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Gene Editing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Gene Editing Market Outlook by Segments
7.1 Gene Editing Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

8 North America Gene Editing Market Analysis and Outlook To 2030
8.1 Introduction to North America Gene Editing Markets in 2024
8.2 North America Gene Editing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Gene Editing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

9 Europe Gene Editing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Gene Editing Markets in 2024
9.2 Europe Gene Editing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Gene Editing Market Size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

10 Asia Pacific Gene Editing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Gene Editing Markets in 2024
10.2 Asia Pacific Gene Editing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Gene Editing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

11 South America Gene Editing Market Analysis and Outlook To 2030
11.1 Introduction to South America Gene Editing Markets in 2024
11.2 South America Gene Editing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Gene Editing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
12 Middle East and Africa Gene Editing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Gene Editing Markets in 2024
12.2 Middle East and Africa Gene Editing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Gene Editing Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
AMS Biotechnology Ltd
Beam Therapeutics Inc
Bluebird Bio Inc
Caribou Biosciences Inc
Cellectis S.A.
Creative Biogene
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript Biotech Corp
Inscripta Inc
Intellia Therapeutics Inc
Lonza Group Ltd
Mammoth Biosciences Inc
Merck KGaA
New England Biolabs Inc
OriGene Technologies Inc
PerkinElmer Inc
Precision Biosciences Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Synthego Corp
Tecan Group Ltd
Thermo Fisher Scientific Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Products and Services
Reagents & Consumables
Software & Systems
Services
By Technology
CRISPR
TALEN
ZFN
ANTISENSE
Others
By Application
Cell Line Engineering
Genetic Engineering
Drug Discovery & Development
Others
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)